Brief: Catalyst Pharmaceuticals Reports Positive Momentum In Second Quarter 2023

Catalyst Pharmaceuticals

01/06/2023 13:18

June 1 (Reuters) - Catalyst Pharmaceuticals Inc
 CPRX.O :
    * CATALYST PHARMACEUTICALS REPORTS POSITIVE MOMENTUM IN
SECOND
QUARTER 2023
    * REAFFIRMS FULL YEAR 2023 TOTAL REVENUE GUIDANCE OF BETWEEN
$375
MILLION AND $385 MILLION
    * REAFFIRMS FULL YEAR 2023 NON-GAAP NET INCOME FORECAST OF
BETWEEN
$195 MILLION AND $205 MILLION
    * FY2023 REVENUE VIEW $380.8 MILLION -- REFINITIV IBES DATA
    * 

Source text for Eikon:  ID:nGNX7T9r2k 
Further company coverage:  CPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))